Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,52 USD | +0,71% | -4,38% | +132,79% |
15/04 | MIND MEDICINE (MINDMED) : Leerink Partners herhaalt koopadvies | ZM |
08/03 | MIND MEDICINE (MINDMED) : RBC Capital Markets handhaaft koopadvies | ZM |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 601 mln. 560 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -94 mln. -87,58 mln. | Nettowinst (verlies) 2025 * | -106 mln. -98,77 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 184 mln. 172 mln. | Nettoliquiditeiten 2025 * | 99,5 mln. 92,71 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-5,37
x | K/w-verhouding 2025 * |
-5,81
x | Werknemers | 57 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 97,59% |
Recentste transcriptie over Mind Medicine (MindMed) Inc.
1 dag | +0,71% | ||
1 week | -4,38% | ||
Lopende maand | -9,36% | ||
1 maand | -18,31% | ||
3 maanden | +133,42% | ||
6 maanden | +227,69% | ||
Lopend jaar | +132,79% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Barrow
CEO | Chief Executive Officer | - | 14-01-21 |
Schond Greenway
DFI | Director of Finance/CFO | 52 | 23-05-22 |
Miri Wernli
PSD | President | 71 | 28-02-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Andreas Krebs
BRD | Director/Board Member | 66 | 29-09-21 |
Suzanne Bruhn
BRD | Director/Board Member | 60 | 11-08-22 |
David Gryska
BRD | Director/Board Member | 68 | 21-06-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 8,52 | +0,71% | 1 096 556 |
24-04-24 | 8,46 | -4,62% | 829 480 |
23-04-24 | 8,87 | +2,19% | 1 200 078 |
22-04-24 | 8,68 | 0,00% | 845 962 |
19-04-24 | 8,68 | -2,58% | 1 517 134 |
uitgestelde koers Nasdaq, 25 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+132,79% | 601 mln. | |
+1,12% | 42,59 mld. | |
+6,77% | 40,65 mld. | |
+47,58% | 40,57 mld. | |
-11,96% | 26,77 mld. | |
+6,01% | 24,81 mld. | |
-24,92% | 18,17 mld. | |
-3,63% | 11,7 mld. | |
+27,16% | 12,05 mld. | |
+7,30% | 11,1 mld. |